Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness

Kaharu C. Sumino, Michael J. Walter, Cassandra L. Mikols, Samantha A. Thompson, Monique Gaudreault-Keener, Max Q. Arens, Eugene Agapov, David Hormozdi, Anne M. Gaynor, Michael J. Holtzman, Gregory A. Storch

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Background: A specific diagnosis of a lower respiratory viral infection is often difficult despite frequent clinical suspicion. This low diagnostic yield may be improved by use of sensitive detection methods and biomarkers. Methods: The prevalence, clinical predictors and inflammatory mediator profile of respiratory viral infection in serious acute respiratory illness were investigated. Sequential bronchoalveolar lavage (BAL) fluids from all patients hospitalised with acute respiratory illness over 12 months (n=283) were tested for the presence of 17 respiratory viruses by multiplex PCR assay and for newly discovered respiratory viruses (bocavirus, WU and KI polyomaviruses) by single-target PCR. BAL samples also underwent conventional testing (direct immunoflorescence and viral culture) for respiratory virus at the clinician's discretion. 27 inflammatory mediators were measured in a subset of the patients (n=64) using a multiplex immunoassay. Results: 39 respiratory viruses were detected in 37 (13.1% of total) patients by molecular testing, including rhinovirus (n=13), influenza virus (n=8), respiratory syncytial virus (n=6), human metapneumovirus (n=3), coronavirus NL63 (n=2), parainfluenza virus (n=2), adenovirus (n=1) and newly discovered viruses (n=4). Molecular methods were 3.8-fold more sensitive than conventional methods. Clinical characteristics alone were insufficient to separate patients with and without respiratory virus. The presence of respiratory virus was associated with increased levels of interferon γ-inducible protein 10 (IP-10) (p<0.001) and eotaxin-1 (p=0.017) in BAL. Conclusions: Respiratory viruses can be found in patients with serious acute respiratory illness by use of PCR assays more frequently than previously appreciated. IP-10 may be a useful biomarker for respiratory viral infection.

Original languageEnglish
Pages (from-to)639-644
Number of pages6
Issue number7
StatePublished - Jul 2010


Dive into the research topics of 'Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness'. Together they form a unique fingerprint.

Cite this